Suppr超能文献

无创通气在哮喘持续状态中的应用:三级重症监护病房16年的经验

Non-invasive ventilation use in status asthmaticus: 16 years of experience in a tertiary intensive care.

作者信息

Bond Kirsten Rl, Horsley Carl Ae, Williams Anthony B

机构信息

Auckland Emergency Department, Auckland City Hospital, Auckland, New Zealand.

Critical Care Complex, Middlemore Hospital, Auckland, New Zealand.

出版信息

Emerg Med Australas. 2018 Apr;30(2):187-192. doi: 10.1111/1742-6723.12876. Epub 2017 Nov 12.

Abstract

OBJECTIVE

To describe the use of non-invasive ventilation (NIV) in adults presenting with status asthmaticus to Middlemore Hospital Critical Care Complex (CCC, South Auckland, New Zealand) from 2000 to 2015.

METHOD

Retrospective review of all adult asthma admissions to the Hospital CCC between 2000 and 2015. Demographic, physiological, treatment data and blood gas results were recorded.

RESULTS

There were 265 asthma admissions to Middlemore Hospital CCC during the study period. The median age was 34 years; 64% were female. NIV was used in 186 admissions, of which eight went on to require intubation and invasive mechanical ventilation (IMV). Twenty-three other admissions received IMV without a trial of NIV and a further 58 were managed with medical care only. The average pH for all admissions was 7.23 and the IMV group had an average pH of 6.99. Forty-five admissions presented with a Glasgow Coma Scale (GCS) score of ≤10. Twenty-five of these were managed with NIV with only one requiring subsequent intubation. The mean duration of NIV in this group was 5 h (range 1-17 h) with a mean ICU and hospital length of stay of 17 h and 3.5 days, respectively. All patients in this group effectively lowered the pCO over a 2 h period with NIV having an average drop of 5.9 kPa and IMV 3.4 kPa.

CONCLUSION

The use of NIV appears to be safe and effective in patients with severe asthma, including selected patients with an altered level of consciousness. NIV was well tolerated with a low need for subsequent intubation.

摘要

目的

描述2000年至2015年期间,无创通气(NIV)在因哮喘持续状态入住新西兰南奥克兰米德尔莫尔医院重症监护中心(CCC)的成人患者中的应用情况。

方法

对2000年至2015年期间所有入住该医院CCC的成年哮喘患者进行回顾性研究。记录人口统计学、生理学、治疗数据及血气结果。

结果

研究期间,共有265例哮喘患者入住米德尔莫尔医院CCC。患者年龄中位数为34岁;64%为女性。186例患者使用了NIV,其中8例随后需要进行气管插管及有创机械通气(IMV)。另有23例患者未进行NIV试验即接受了IMV,还有58例患者仅接受药物治疗。所有患者的平均pH值为7.23,IMV组的平均pH值为6.99。45例患者的格拉斯哥昏迷量表(GCS)评分≤10分。其中25例接受了NIV治疗,只有1例随后需要进行气管插管。该组患者NIV的平均持续时间为5小时(范围为1 - 17小时),平均ICU住院时间和住院时间分别为17小时和3.5天。该组所有患者在2小时内均有效降低了pCO,NIV组平均下降5.9kPa,IMV组平均下降3.4kPa。

结论

NIV在重症哮喘患者中,包括部分意识水平改变的患者中,似乎是安全有效的。NIV耐受性良好,后续气管插管需求较低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验